What is 5-Amino-1MQ?
5-Amino-1MQ is a small molecule inhibitor of NNMT (nicotinamide N-methyltransferase), an enzyme that is overexpressed in obese and aged fat tissue. By inhibiting NNMT, 5-Amino-1MQ activates fat cell metabolism, increases NAD+ levels in adipose tissue, and has been shown to reduce fat mass and improve metabolic health in animal models.
Mechanism of Action
NNMT consumes SAM (S-adenosylmethionine) and NAD+ precursors in fat cells, suppressing metabolism. 5-Amino-1MQ inhibits NNMT, allowing NAD+ levels to rise in adipose tissue, activating SIRT1 and other NAD+-dependent enzymes, increasing fat cell energy expenditure, and promoting fat mobilization.
5-Amino-1MQ Dosing Protocol
50–100 mg/day oral. Some researchers use 25–50 mg twice daily. No established clinical protocol. Animal studies used 5 mg/kg/day. Human equivalent dose: approximately 0.4–0.8 mg/kg/day.
Want a personalized protocol? Tell PepBot your goals, health status, and experience level for a custom 5-Amino-1MQ protocol.
5-Amino-1MQ Benefits
Side Effect Profile
Limited human data. Animal studies show good tolerability. No significant adverse effects reported at research doses.
5-Amino-1MQ Stacking Guide
5-Amino-1MQ works synergistically with these compounds. Click any to learn more, or ask PepBot to build you a complete stack.
Research & Citations
Frequently Asked Questions about 5-Amino-1MQ
How does 5-Amino-1MQ work differently from GLP-1 agonists?
Still have questions about 5-Amino-1MQ?
PepBot has encyclopedic knowledge of 5-Amino-1MQ — dosing, stacking, interactions, latest research, and personalized protocols. Ask anything.